Trial intelligence / Profile preview

Albuterol BOI vs MDI in Asthmatics with Poor Coordination

NCT00054964Phase 2Completed

Sponsor
Teva Pharmaceutical Industries Ltd.
Start
Mar 2003
Primary completion
Aug 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of albuterol spiromax in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2003; status: completed.

02

Drugs

albuterol spiromax
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00054964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00054964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call